CUBE vs MRK · P/E 25, rev $1.07B vs P/E 33, rev $65.01B
CubeSmart (CUBE) versus Merck & Company Inc (MRK) — a side-by-side from cached financials, not a winner call.
CubeSmart (CUBE) is a reit - industrial company listed on US.
Merck & Company Inc (MRK) is a drug manufacturers - general company listed on NYSE. It is led by Rob Davis.
Latest reported CUBE revenue for 2024-12-31 was $1.07B. Net income was $391.9M. Revenue was up 1.5% from 2023-12-31 to 2024-12-31. CUBE currently screens at market cap $9.69B and trailing P/E 25.0.
Latest reported MRK revenue for 2025-12-31 was $65.01B. Net income was $18.25B. Revenue was up 1.3% from 2024-12-31 to 2025-12-31. MRK currently screens at market cap $285.12B and trailing P/E 32.5.
CUBE currently screens at market cap $9.69B and trailing P/E 25.0. MRK currently screens at market cap $285.12B and trailing P/E 32.5.
Not investment advice. Open the CUBE and MRK stock pages for the full models.
Not investment advice.